Chemoinformaics analysis of 2-Methoxy-4-vinylphenol
| Molecular Weight | 150.177 | nRot | 2 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
| Exact Molecular Weight | 150.068 | nRing | 1 |
| Solubility: LogS | -2.071 | nHRing | 0 |
| Solubility: LogP | 2.251 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 23.3019 |
| nHD | 1 | BPOL | 11.7681 |
| QED | 0.699 |
| Synth | 1.931 |
| Natural Product Likeliness | 1.011 |
| NR-PPAR-gamma | 0.057 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.169 |
| HIA | 0.005 |
| CACO-2 | -4.453 |
| MDCK | 0.0000234 |
| BBB | 0.344 |
| PPB | 0.872596 |
| VDSS | 0.918 |
| FU | 0.112989 |
| CYP1A2-inh | 0.901 |
| CYP1A2-sub | 0.888 |
| CYP2c19-inh | 0.102 |
| CYP2c19-sub | 0.682 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.882 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.898 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.337 |
| CL | 13.581 |
| T12 | 0.874 |
| hERG | 0.024 |
| Ames | 0.1 |
| ROA | 0.348 |
| SkinSen | 0.596 |
| Carcinogencity | 0.73 |
| EI | 0.99 |
| Respiratory | 0.787 |
| NR-Aromatase | 0.038 |
| Antiviral | No |
| Prediction | 0.890738 |